Literature DB >> 26171208

Preoperative C-reactive protein as a prognostic predictor for upper tract urothelial carcinoma: A systematic review and meta-analysis.

You Luo1, Sheng Jun Fu1, Dong Li She1, H U Xiong1, L I Yang1.   

Abstract

Upper tract urothelial carcinoma (UTUC) is a relatively rare and highly aggressive tumor. However, the prognosis of UTUC is rarely predicted accurately due to the lack of reliable biomarkers. C-reactive protein (CRP) has been found to be correlated with several types of cancer. In this study, we performed a systematic review and meta-analysis to determine the association between CRP levels and prognosis in UTUC. A computerized search was conducted through PubMed, Embase, Web of Science, the Cochrane Library and CBM databases to identify clinical studies that have evaluated the association between preoperative CRP levels and prognosis of UTUC. The prognostic outcomes included recurrence-free survival (RFS), cancer-specific survival (CSS) and overall survival (OS). We extracted and synthesized corresponding hazard ratios (HRs) and confidence intervals (CIs) using Review Manager 5.3 software. We identified 7 retrospective cohort studies including a total of 1,919 patients and analyzed these studies using univariate and multivariate models. Our meta-analysis results revealed that RFS and CSS were significantly different between patients with elevated CRP levels and those with low CRP levels (P<0.0001 and P<0.00001, respectively); however, that was not the case for OS (P=0.22) in the multivariate or the univariate model. The pooled HR of RFS was 2.90 (95% CI: 1.87-4.51, P<0.00001) in the univariate analysis and 1.57 (95% CI: 1.26-1.97, P<0.0001) in the multivariate analysis. The pooled HRs of CSS were 2.78 (95% CI: 1.75-4.43, P<0.0001) and 1.64 (95% CI: 1.32-2.03, P<0.00001) in the univariate and multivariate analysis, respectively. However, the pooled HRs of OS were not significant in the univariate [1.24 (95% CI: 0.72-2.15, P=0.43)] or the multivariate analysis [1.24 (95% CI: 0.88-1.75, P=0.22)]. In conclusion, our meta-analysis results suggested that CRP level may be a prognostic predictor in UTUC.

Entities:  

Keywords:  C-reactive protein; meta-analysis; prognosis; survival; upper tract urothelial carcinoma

Year:  2015        PMID: 26171208      PMCID: PMC4486906          DOI: 10.3892/mco.2015.553

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  28 in total

Review 1.  Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature.

Authors:  Giovanni Lughezzani; Maximilian Burger; Vitaly Margulis; Surena F Matin; Giacomo Novara; Morgan Roupret; Shahrokh F Shariat; Christopher G Wood; Richard Zigeuner
Journal:  Eur Urol       Date:  2012-02-23       Impact factor: 20.096

Review 2.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 3.  A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma.

Authors:  Jeffrey J Leow; William Martin-Doyle; André P Fay; Toni K Choueiri; Steven L Chang; Joaquim Bellmunt
Journal:  Eur Urol       Date:  2014-03-16       Impact factor: 20.096

4.  European guidelines on upper tract urothelial carcinomas: 2013 update.

Authors:  Morgan Rouprêt; Marko Babjuk; Eva Compérat; Richard Zigeuner; Richard Sylvester; Max Burger; Nigel Cowan; Andreas Böhle; Bas W G Van Rhijn; Eero Kaasinen; Joan Palou; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2013-03-19       Impact factor: 20.096

5.  Prognostic value of circulating C-reactive protein levels in patients with non-small cell lung cancer: a systematic review with meta-analysis.

Authors:  Ying Jin; Yan Sun; Xun Shi; Jun Zhao; Lei Shi; Xinmin Yu
Journal:  J Cancer Res Ther       Date:  2014-11       Impact factor: 1.805

6.  Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.

Authors:  Jay D Raman; R Ernest Sosa; E Darracott Vaughan; Douglas S Scherr
Journal:  Urology       Date:  2007-02       Impact factor: 2.649

7.  Bladder cancer.

Authors:  Peter E Clark; Neeraj Agarwal; Matthew C Biagioli; Mario A Eisenberger; Richard E Greenberg; Harry W Herr; Brant A Inman; Deborah A Kuban; Timothy M Kuzel; Subodh M Lele; Jeff Michalski; Lance C Pagliaro; Sumanta K Pal; Anthony Patterson; Elizabeth R Plimack; Kamal S Pohar; Michael P Porter; Jerome P Richie; Wade J Sexton; William U Shipley; Eric J Small; Philippe E Spiess; Donald L Trump; Geoffrey Wile; Timothy G Wilson; Mary Dwyer; Maria Ho
Journal:  J Natl Compr Canc Netw       Date:  2013-04-01       Impact factor: 11.908

8.  Predictors of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: an inflammation-based prognostic score.

Authors:  Yang Hyun Cho; Young Ho Seo; Seung Jun Chung; Insang Hwang; Ho Song Yu; Sun-Ouck Kim; Seung Il Jung; Taek Won Kang; Dong Deuk Kwon; Kwangsung Park; Jun Eul Hwang; Suk Hee Heo; Geun Soo Kim; Eu Chang Hwang
Journal:  Korean J Urol       Date:  2014-07-11

9.  Prognostic role of C-reactive protein in hepatocellular carcinoma: a systematic review and meta-analysis.

Authors:  Zhiyun Zheng; Lin Zhou; Sheng Gao; Zhe Yang; Jia Yao; Shusen Zheng
Journal:  Int J Med Sci       Date:  2013-04-01       Impact factor: 3.738

10.  Practical methods for incorporating summary time-to-event data into meta-analysis.

Authors:  Jayne F Tierney; Lesley A Stewart; Davina Ghersi; Sarah Burdett; Matthew R Sydes
Journal:  Trials       Date:  2007-06-07       Impact factor: 2.279

View more
  9 in total

Review 1.  Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review.

Authors:  Aurélie Mbeutcha; Morgan Rouprêt; Ashish M Kamat; Pierre I Karakiewicz; Nathan Lawrentschuk; Giacomo Novara; Jay D Raman; Christian Seitz; Evanguelos Xylinas; Shahrokh F Shariat
Journal:  World J Urol       Date:  2016-04-21       Impact factor: 4.226

2.  Prognostic impact of interleukin-6 and C-reactive protein on patients with breast cancer.

Authors:  Tatsuo Shimura; Masahiko Shibata; Kenji Gonda; Yuko Murakami; Masaru Noda; Kazunoshin Tachibana; Noriko Abe; Tohru Ohtake
Journal:  Oncol Lett       Date:  2019-03-21       Impact factor: 2.967

Review 3.  Risk stratification for kidney sparing procedure in upper tract urothelial carcinoma.

Authors:  Zine-Eddine Khene; Romain Mathieu; Solène-Florence Kammerer-Jacquet; Thomas Seisen; Morgan Roupret; Shahrokh F Shariat; Benoit Peyronnet; Karim Bensalah
Journal:  Transl Androl Urol       Date:  2016-10

Review 4.  Predictive models and prognostic factors for upper tract urothelial carcinoma: a comprehensive review of the literature.

Authors:  Aurélie Mbeutcha; Romain Mathieu; Morgan Rouprêt; Kilian M Gust; Alberto Briganti; Pierre I Karakiewicz; Shahrokh F Shariat
Journal:  Transl Androl Urol       Date:  2016-10

5.  Roles of preoperative C-reactive protein are more relevant in buccal cancer than other subsites.

Authors:  Shiao Fwu Tai; Huei-Tzu Chien; Chi-Kuang Young; Chung-Kang Tsao; Alba de Pablo; Kang-Hsing Fan; Chun-Ta Liao; Hung-Ming Wang; Chung-Jan Kang; Joseph Tung-Chieh Chang; Shiang-Fu Huang
Journal:  World J Surg Oncol       Date:  2017-02-16       Impact factor: 2.754

Review 6.  Risk stratification for upper tract urinary carcinoma.

Authors:  Daniel Benamran; Thomas Seisen; Elias Naoum; Christophe Vaessen; Jérome Parra; Pierre Mozer; Shahrokh F Shariat; Morgan Rouprêt
Journal:  Transl Androl Urol       Date:  2020-08

7.  Prognostic nutritional index before surgical treatment may serve as a prognostic biomarker for patients with upper tract urothelial carcinoma: A systematic review and meta-analysis.

Authors:  Chunyang Meng; Lijian Gan; Kangsen Li; Fulin Yi; Lei Peng; Jinze Li; Yunxiang Li
Journal:  Front Nutr       Date:  2022-09-23

8.  The systemic inflammation-based Glasgow Prognostic Score as a powerful prognostic factor in patients with upper tract urothelial carcinoma.

Authors:  Teruo Inamoto; Hideyasu Matsuyama; Shigeru Sakano; Naokazu Ibuki; Kiyoshi Takahara; Kazumasa Komura; Tomoaki Takai; Takuya Tsujino; Yuki Yoshikawa; Koichiro Minami; Kazuhiro Nagao; Ryo Inoue; Haruhito Azuma
Journal:  Oncotarget       Date:  2017-11-23

Review 9.  Global assessment of C-reactive protein and health-related outcomes: an umbrella review of evidence from observational studies and Mendelian randomization studies.

Authors:  Georgios Markozannes; Charalampia Koutsioumpa; Sofia Cividini; Grace Monori; Konstantinos K Tsilidis; Nikolaos Kretsavos; Evropi Theodoratou; Dipender Gill; John Pa Ioannidis; Ioanna Tzoulaki
Journal:  Eur J Epidemiol       Date:  2020-09-25       Impact factor: 8.082

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.